XML 28 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Cash Flows
€ in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2023
EUR (€)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
EUR (€)
Dec. 31, 2021
EUR (€)
Cash flows from operating activities        
Profit (loss) for the year € 625 $ 693 € 140 [1] € (19,640) [1]
Adjustments for:        
Financing expenses, net 3,034 3,355 2,466 26,884
Profit from settlement of derivatives contract (407)
Impairment losses on assets of disposal groups classified as held-for-sale 2,565 2,837
Depreciation and amortization 16,473 18,220 16,092 15,116
Share-based payment transactions 121 134 127 63
Share of profits of equity accounted investees (4,320) (4,778) (1,206) [1] (117) [1]
Change in trade receivables and other receivables (302) (334) 724 (1,883)
Change in other assets (681) (753) (209) (545)
Change in receivables from concessions project 1,778 1,967 (521) 1,580
Change in trade payables (45) (50) 1,697 154
Change in other payables (2,235) (2,472) 3,807 2,380
Income tax expense (tax benefit) (1,852) (2,048) 2,103 (2,281)
Income taxes paid (912) (1,009) (6,337) (94)
Repayment of interest on loan from an equity accounted investee 1,501 1,660 859
Interest received 2,936 3,247 1,896 1,844
Interest paid (10,082) (11,151) (9,459) (7,801)
Total adjustment to reconcile profit and loss 7,979 8,825 11,180 35,752
Net cash provided by operating activities 8,604 9,518 11,320 16,112
Cash flows from investing activities:        
Acquisition of fixed assets (58,848) (65,088) (46,644) (79,696)
Interest paid capitalized to fixed assets (2,283) (2,525) (1,966) (1,189)
Repayment of loan to an equity accounted investee 1,324 1,464 149 1,400
Loan to an equity accounted investee (128) (142) (128) (335)
Advances on account of investments (421) (466) (774)
Proceeds from advances on account of investments in process 2,218 2,453
Proceeds from sales of (investment in) marketable securities 2,837 3,138 (1,062) (112)
Investment in settlement of derivatives, net (528) (976)
Proceed from (investment in) restricted cash, net 840 929 (4,873) (5,990)
Proceeds from (investment in) short term deposit (1,092) (1,208) 27,645 (18,599)
Net cash used in investing activities (55,553) (61,445) (28,181) (105,497)
Cash flows from financing activities:        
Sale of shares in subsidiaries to non-controlling interests 1,400
Proceeds from options 36 49
Cost associated with long-term loans (1,877) (2,076) (9,988) (2,796)
Payment of principal of lease liabilities (1,156) (1,279) (5,703) (4,803)
Proceeds from long-term loans 32,157 35,567 215,170 32,947
Repayment of long-term loans (12,736) (14,087) (153,751) (18,905)
Repayment of Debentures (17,763) (19,647) (19,764) (30,730)
Repayment of SWAP instrument associated with long term loans (3,290)
Proceed from settlement of derivatives, net 3,800
Proceeds from issue of convertible debentures 15,571
Proceeds from issuance of Debentures, net 55,808 61,726 57,717
Proceeds from issuance / exercise of warrants 3,746
Net cash provided by financing activities 54,433 60,204 26,510 54,196
Effect of exchange rate fluctuations on cash and cash equivalents (2,387) (2,640) (4,420) 9,573
Increase (decrease) in cash and cash equivalents 5,097 5,637 5,229 (25,616)
Cash and cash equivalents at the beginning of year 46,458 51,384 41,229 66,845
Cash from disposal groups classified as held-for-sale (428) (473)
Cash and cash equivalents at the end of the year € 51,127 $ 56,548 € 46,458 € 41,229
[1] Reclassified due to discontinued operation - see Note 23.